Gary Romano

Gary Romano has a diverse work experience in the pharmaceutical industry. GARY is currently serving as the Chief Medical Officer at Alector, a position they started in 2022. Prior to that, they founded and served as the Principal of Neurotherapeutic Development Advisors, LLC from 2021 to 2022. Gary also worked as the Chief Medical Officer at Passage Bio from 2019 to 2021. Before that, they held various roles at Janssen, Pharmaceutical Companies of Johnson and Johnson, including Head of Development for Alzheimer's Disease and Neurology, and Head of Neuroscience Biomarkers. Gary also had positions at J&J as the Pain Therapeutic Area Head and Senior Director. Their earlier experience includes working at Merck as the Director of CNS from 2002 to 2006.

Gary Romano's education history is as follows:

From 1988 to 1992, they attended The Johns Hopkins University School of Medicine and obtained their MD degree.

Following that, between 1992 and 1997, they pursued their Residency and Fellowship at the University of Pennsylvania, specializing in Neurology.

Prior to that, from 1983 to 1988, they attended Rockefeller University, where they completed their PhD in Molecular Neuroscience.

Their undergraduate education was completed at Trinity College from 1978 to 1982, where they earned a BS degree in Biology.

Additionally, they also obtained a Ph.D. in Molecular Neuroscience from The Rockefeller University, although the specific timeframe is unknown.

Similarly, they earned a B.S. degree in Biology, General from Trinity College-Hartford, but the exact dates are not provided.